Navigation Links
TriLink Awarded a Phase II Grant for a Second Hot Start PCR Project
Date:5/6/2008

SAN DIEGO, May 6 /PRNewswire/ -- TriLink BioTechnologies (TriLink), a leading provider of custom nucleic acid-based compounds, has been awarded a Phase II Small Business Innovation Research (SBIR) grant of approximately $750,000 to continue its investigation of modified dNTPs to improve the fidelity of PCR reactions. Phase I studies demonstrated that TriLink's unique dNTP modifications enhanced PCR performance by increasing amplicon formation while reducing off-target amplicon formation. In the second phase of the program, TriLink will look to further expand upon Phase I studies to develop novel solutions for endpoint PCR, real-time PCR, multiplex PCR, fast PCR, and more advanced PCR applications. TriLink will also optimize the synthetic route for scale-up of the modified dNTPs and will develop robust PCR assay recommendations in preparation for commercialization of the technology in early 2009. This is the third Phase II grant TriLink has been awarded.

"We believe that this novel approach to improving PCR fidelity complements our CleanAmp(TM) product line very nicely," said Dr. Richard Hogrefe, CEO and President of TriLink. "Now we offer modified primers and modified dNTPs. The CleanAmp(TM) Primers will solve specific assay issues whereas the modified dNTPs will be a more general solution. Either product will provide a very cost effective solution when compared to the modified enzymes available on the market."

About TriLink

TriLink BioTechnologies, Inc. manufactures custom oligonucleotides, nucleoside triphosphates and synthesis reagents for research and diagnostic laboratories. In addition, it offers radiolabeling services, custom chemistry, contract research services and GMP production facilities for oligos and small molecules. TriLink's solutions help advance drug discovery and biomedical research. For more information visit http://www.trilinkbiotech.com or contact:

TriL
'/>"/>

SOURCE TriLink BioTechnologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
2. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
3. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
4. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
5. National Jewish, Brigham and Womens Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD
6. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
7. Congressional Funds Awarded for Testing of Antimicrobial Copper Metals
8. DiObex, Inc. Awarded Patent for the Prevention of Insulin-Induced Hypoglycemia
9. Fundamental Applied Biology, Inc. Is Awarded SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell Free Technology
10. New Patent Awarded for Antigen-Sparing Vaccines that Elicit Robust Immunity
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 2014  ConvaTec, a privately-held medical products and technologies ... been appointed chief financial officer of the company, effective ... executive vice president and chief financial officer of Elan ... Mr. Clerkin was part of a senior team that ... its sale to Perrigo, a pharmaceutical manufacturer, in December ...
(Date:7/22/2014)... , July 22, 2014  According to the American ... children spend on digital devices. An AOA survey reports ... 10 and 17 estimate they use an electronic device ... separate AOA survey of parents revealed that only 40 ... device for that same amount of time. Eye doctors ...
(Date:7/22/2014)... , July 22, 2014  NeuroSigma, Inc. (NeuroSigma), ... focused on commercialization of its non-invasive Monarch ... and neuropsychiatric disorders, today announced that enrollment has begun ... nerve stimulation (eTNS) as adjunctive therapy for the treatment ... being conducted at the Olive View-UCLA Medical Center in ...
Breaking Medicine Technology:ConvaTec Names Nigel Clerkin Chief Financial Officer 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 3Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 4Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 2Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 3Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 4Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 5
... Infection Prevention Professionals With Guidelines,and Tools, ... Association for,Professionals in Infection Control and ... new educational initiatives aimed at eliminating,healthcare-associated ... and the three infections that the ...
... Innocoll, Inc., a privately-held,specialty pharmaceutical company, announced ... clinical trials sponsored by its wholly owned ... TOPICAL for the,treatment and prevention of infected ... GENTAMICIN TOPICAL is a biodegradable and fully ...
Cached Medicine Technology:APIC Launches 'Targeting Zero' Initiative to Eradicate C. Difficile and Infections Deemed Preventable By CMS 2APIC Launches 'Targeting Zero' Initiative to Eradicate C. Difficile and Infections Deemed Preventable By CMS 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers 4
(Date:7/22/2014)... July 22, 2014 (HealthDay News) -- Genetic fragments of the ... barn where an infected camel was kept, a new study ... to determine if Middle East Respiratory Syndrome (MERS) can be ... air samples over three consecutive days from a camel barn ... of the town of Jeddah, Saudi Arabia. The man later ...
(Date:7/22/2014)... electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS), ... Like antidepressant medications, however, they typically have a ... several weeks of regular ECT treatments before a ... an impetus to develop antidepressant treatments that act ... (LFMS) is one such potential new treatment with ...
(Date:7/22/2014)... The “Human Insulin Market by Product ... Modern Human Insulin (Rapid Acting, Long Acting, Premixed)], ... Others) - Forecast to 2019” provides a detailed ... current market trends, and strategies impacting the global ... forecasts of the revenue and share analysis. , ...
(Date:7/22/2014)... Cloud+MD Office 2.0 is a ... medical software and services, designed by experienced healthcare ... “Actionable Information” to help Independent Physician Practices, New ... Services optimize a wide range of business processes ... Noticeable Cost Reductions and Better Patient Care. ...
(Date:7/22/2014)... 2014 For the past nine years, ... been working in tandem to help thousands of cancer ... to care, and help survivors connect to resources dealing ... expanded their partnership to include referrals from PAF to ... the other practical, emotional, and financial issues that accompany ...
Breaking Medicine News(10 mins):Health News:MERS Virus Found in Air in Camel Barn 2Health News:Low strength brain stimulation may be effective for depression 2Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 5Health News:Cloud-MD Software will soon Receive MU2 Certification 2Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 2Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 3
... and NEW YORK, Feb. 11 ActivCore ... exclusive distributor of Redcord,products in the United ... with,Wellness in Motion (WIM). ActivCore will ... Training Network that will serve,therapy professionals, chiropractors, ...
... to Make Women,s Concerns Central to National Health ... Stabenow (D-MI), House Democratic Co-Chair of the Congressional ... other Congressional leaders introduced a resolution today that ... will make women,s needs a key part of ...
... announces FDA 510(k) Class,II clearance for the world,s ... respiration rates, bed occupancy and,movement. Under the brand ... device in the US and Canada under an ... 2000 received the sign off from,the FDA,s Division ...
... Demonstrates That Small Gains in Member Retention ... Market research conducted on behalf of ... can significantly improve revenue generation by establishing ... host of economic factors are currently driving ...
... (NYSE: HRC ) invites you to listen ... Investor Relations, Communications and Global Brand,Development, Hill-Rom. He ... in Las Vegas on Tuesday, February 24, 2009, at,9:40 ... invited to listen to the live audio-only webcast via ...
... through Associate Giving CampaignDENVER, Feb. 11 Anthem ... a long history of giving back to the ... 2008, the strong commitment continued through financial support ... Foundation and the generosity of the company,s associates.Anthem,s ...
Cached Medicine News:Health News:ActivCore LLC Announces Strategic Partnership with Wellness in Motion 2Health News:Congressional Leaders, Public Health Experts Announce New Framework to Promote Women's Health 2Health News:Congressional Leaders, Public Health Experts Announce New Framework to Promote Women's Health 3Health News:Sensiotec Announces FDA 510(k) Class II Clearance for the World's First UWB Healthcare Unbound, Wireless, Non-Contact, Vital Signs and Movement Monitor 2Health News:Lowering Health Insurance Member Disenrollment Can Generate up to $100 Million in Incremental Revenue for Health Plans 2Health News:Lowering Health Insurance Member Disenrollment Can Generate up to $100 Million in Incremental Revenue for Health Plans 3Health News:Anthem Blue Cross and Blue Shield in Colorado and its Foundation Commit $1.6 Million in 2008 2Health News:Anthem Blue Cross and Blue Shield in Colorado and its Foundation Commit $1.6 Million in 2008 3Health News:Anthem Blue Cross and Blue Shield in Colorado and its Foundation Commit $1.6 Million in 2008 4
Dnase-free, with an integral filter to protect against carry over and contamination from aerosols...
... TowerPack is an innovative, quick and ... Tips. Use 60% less space on ... plastic. With this amazingly easy-to-use, one-hand ... for the whole range of Diamond ...
300 L, Racked, 96 tips/rack Recommended for 250 and 300 L pipettes. Can also be used with 20, 25, 50, 100 and 200 L pipette...
... to optimize the accuracy and precision of ... is widely recognized by customers throughout the ... over the years and now covers a ... including filter tips, certified pure tips, stepper ...
Medicine Products: